Propofol target controlled infusion with the use of liver retractor

Predictive performance of propofol target controlled infusion with the use of liver retractor

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1021230068

Enrollment

Registered

2024-03-29

Start date

2024-04-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Not specified

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The subjects were 16 adult patients who were scheduled to undergo laparoscopic liver retractor surgery at our hospital and who met all of the following criteria: 1) ASA (American Society of Anesthesiologists) classification 1-3 2) Written consent has been obtained for the use and publication of anesthesia-related data.

Exclusion criteria

Exclusion criteria: Patients with any of the following will be excluded: 1) Under 18 years old 2) Liver disease 3) Severe arrhythmia 4) Allergic to propofol

Design outcomes

Primary

Measure	Time frame
Difference between the predicted propofol blood concentration displayed on the TCI pump and the actual blood concentration	—

Contacts

Public ContactShinju Obara

Fukushima Medical University Hospital

shinjn@fmu.ac.jp+81-24-547-1342

Outcome results